Leading Pharma, LLC recalls Furosemide Tablets
- Published
- 29 Apr 2026
- Units affected
- 9384 bottles
- Agency
- FDA
- Country
- United States
The hazard
CGMP Deviations; presence of N-nitroso-Furosemide (NNF) above the recommended intake limit.
Classification: Class II — this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.
What to do
Do not stop a prescribed medicine without talking to your doctor or pharmacist first. Ask them about a replacement, and return the recalled product to the pharmacy.
- Check the lot number on the box or bottle.
- Talk to your pharmacist or doctor before stopping any prescribed medicine.
- Return the product to the pharmacy for safe disposal.
Product details
Furosemide Tablets, USP, 80 mg, 100 Tablets bottles, Rx only, Manufactured by: Leading Pharma, LLC, Fairfield, NJ 07004, NDC 69315-118-01
- Brand / company
- Leading Pharma, LLC
- Codes / lots
- Lots# H03125, H03225, H03325, Exp Date: 2027/08
- Distribution
- US Nationwide.
- Recall status
- Ongoing
Source: U.S. Food and Drug Administration, published 29 Apr 2026. CheckMyRecalls reproduces the official notice in summary; always confirm the details with the original notice.